A Survey of COVID-19 Preparedness Among Hospitals in Idaho.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 12 5 2020
medline: 30 9 2020
entrez: 12 5 2020
Statut: ppublish

Résumé

SARS-CoV-2 has been implicated in the largest recorded coronavirus outbreak to date. Initially, most COVID-19 cases were in China, but the virus has spread to more than 184 countries worldwide, and the United States currently has more cases than any other country. With person-to-person spread expanding in the United States, we describe hospital preparedness for managing suspected and confirmed COVID-19 patients. Cross-sectional survey focused on various elements of respiratory disease preparedness. Critical access hospitals (CAHs) and acute-care hospitals (ACHs) in Idaho. The electronic survey was sent to infection preventionists (IPs) and nurse administrators in 44 hospitals in Idaho. Overall, 32 (73%) hospitals responded to the survey. Participating facilities reported their preparedness with respect to existing, formalized structures for managing infectious disease incidents-specifically COVID-19-as well as availability of resources, such as isolation rooms and personal protective equipment, for safely managing suspected and confirmed COVID-19 cases. Hospitals covered by the survey had varying levels of preparedness for managing COVID-19 cases, with differences across the various categories of interest in this study. Although the study reveals strengths, including in application of emergency management and infection control frameworks, it also suggests that other areas, such as consistent implementation of federal guidelines and requirements for infection prevention, are potential areas for strengthening preparedness for SARS-CoV-2 and other respiratory pathogens with pandemic potential.

Sections du résumé

BACKGROUND
SARS-CoV-2 has been implicated in the largest recorded coronavirus outbreak to date. Initially, most COVID-19 cases were in China, but the virus has spread to more than 184 countries worldwide, and the United States currently has more cases than any other country.
OBJECTIVE
With person-to-person spread expanding in the United States, we describe hospital preparedness for managing suspected and confirmed COVID-19 patients.
DESIGN
Cross-sectional survey focused on various elements of respiratory disease preparedness.
SETTING
Critical access hospitals (CAHs) and acute-care hospitals (ACHs) in Idaho.
METHODS
The electronic survey was sent to infection preventionists (IPs) and nurse administrators in 44 hospitals in Idaho.
RESULTS
Overall, 32 (73%) hospitals responded to the survey. Participating facilities reported their preparedness with respect to existing, formalized structures for managing infectious disease incidents-specifically COVID-19-as well as availability of resources, such as isolation rooms and personal protective equipment, for safely managing suspected and confirmed COVID-19 cases.
CONCLUSIONS
Hospitals covered by the survey had varying levels of preparedness for managing COVID-19 cases, with differences across the various categories of interest in this study. Although the study reveals strengths, including in application of emergency management and infection control frameworks, it also suggests that other areas, such as consistent implementation of federal guidelines and requirements for infection prevention, are potential areas for strengthening preparedness for SARS-CoV-2 and other respiratory pathogens with pandemic potential.

Identifiants

pubmed: 32389150
pii: S0899823X20002184
doi: 10.1017/ice.2020.218
pmc: PMC7294077
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1003-1010

Références

N Engl J Med. 2015 Apr 9;372(15):1381-4
pubmed: 25853741
Am J Infect Control. 2020 Jul;48(7):795-797
pubmed: 31839277
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S223-7, discussion S226
pubmed: 16378050
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nat Med. 2004 Apr;10(4):368-73
pubmed: 15034574
J Virol. 2005 Jan;79(2):884-95
pubmed: 15613317

Auteurs

Anubhav Kanwar (A)

Infectious Diseases, HIV and Travel Medicine, Tri-State Memorial Hospital, Clarkston, Washinton.

Susan Heppler (S)

Infection Prevention, Saint Alphonsus Medical Center, Nampa, Idaho.

Kalpana Kanwar (K)

Spokane Falls Community College, Pullman, Washington.

Christopher K Brown (CK)

Directorate of Technical Support and Emergency Management, Occupational Safety and Health Administration, US Department of Labor, Washington, DC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH